Loading…

Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort

Human exposure to per‐ and polyfluoroalkyl substances (PFAS) occurs globally through contaminated food, dust, and drinking water. Studies of PFAS and thyroid cancer have been limited. We conducted a nested case‐control study of prediagnostic serum levels of 19 PFAS and papillary thyroid cancer (400...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2024-03, Vol.154 (6), p.979-991
Main Authors: Madrigal, Jessica M., Troisi, Rebecca, Surcel, Heljä‐Marja, Öhman, Hanna, Kivelä, Juha, Kiviranta, Hannu, Rantakokko, Panu, Koponen, Jani, Medgyesi, Danielle N., Kitahara, Cari M., McGlynn, Katherine A., Sampson, Joshua, Albert, Paul S., Ward, Mary H., Jones, Rena R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3
cites cdi_FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3
container_end_page 991
container_issue 6
container_start_page 979
container_title International journal of cancer
container_volume 154
creator Madrigal, Jessica M.
Troisi, Rebecca
Surcel, Heljä‐Marja
Öhman, Hanna
Kivelä, Juha
Kiviranta, Hannu
Rantakokko, Panu
Koponen, Jani
Medgyesi, Danielle N.
Kitahara, Cari M.
McGlynn, Katherine A.
Sampson, Joshua
Albert, Paul S.
Ward, Mary H.
Jones, Rena R.
description Human exposure to per‐ and polyfluoroalkyl substances (PFAS) occurs globally through contaminated food, dust, and drinking water. Studies of PFAS and thyroid cancer have been limited. We conducted a nested case‐control study of prediagnostic serum levels of 19 PFAS and papillary thyroid cancer (400 cases, 400 controls) in the Finnish Maternity Cohort (pregnancies 1986‐2010; follow‐up through 2016), individually matched on sample year and age. We used conditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for log2 transformed and categorical exposures, overall and stratified by calendar period, birth cohort, and median age at diagnosis. We adjusted for other PFAS with Spearman correlation rho = 0.3‐0.6. Seven PFAS, including perfluoroctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), N‐ethyl‐perfluorooctane sulfonamidoacetic acid (EtFOSAA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluorohexane sulfonic acid (PFHxS) were detected in >50% of women. These PFAS were not associated with risk of thyroid cancer, except for PFHxS, which was inversely associated (OR log2 = 0.82, 95% CI: 0.70‐0.97). We observed suggestive but imprecise increased risks associated with PFOA, PFOS, and EtFOSAA for those diagnosed at ages
doi_str_mv 10.1002/ijc.34776
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2884185172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2884185172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EotPCghdAltjAIq2vf-J4iUYUilqVBawjx3EYTzN2sB2h7HiEPmOfpO5MywKJ1ZXu_c7R0T0IvQFyCoTQM7c1p4xLWT9DKyBKVoSCeI5W5UYqCaw-QscpbQkBEIS_REdMKkKpFCt0-y3a3umfPqTsDE42zjtsgjfW56izCz7hMODJxrs_t1j7Hk9hXIZxDjHo8WYZcZq7lHURpP05unSzV-jJjaOOC86bJQbXY_MARex82Vh87rx3aYOvdLbRu7zgddiEmF-hF4Mek339OE_Qj_NP39dfqsvrzxfrj5eVYYLVVd8LGGBgjQHOmKkVMMm0MsRwzoUVnehr1VvomlroxjS8G4igalBcKN6Zjp2g9wffKYZfs0253blkbInsbZhTS5uGQyNA0oK--wfdhjn6kq6lCiRQqKUs1IcDZWJIKdqhnaLblQe0QNqHmtpSU7uvqbBvHx3nbmf7v-RTLwU4OwC_3WiX_zu1F1_XB8t7SzmfQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917121677</pqid></control><display><type>article</type><title>Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Madrigal, Jessica M. ; Troisi, Rebecca ; Surcel, Heljä‐Marja ; Öhman, Hanna ; Kivelä, Juha ; Kiviranta, Hannu ; Rantakokko, Panu ; Koponen, Jani ; Medgyesi, Danielle N. ; Kitahara, Cari M. ; McGlynn, Katherine A. ; Sampson, Joshua ; Albert, Paul S. ; Ward, Mary H. ; Jones, Rena R.</creator><creatorcontrib>Madrigal, Jessica M. ; Troisi, Rebecca ; Surcel, Heljä‐Marja ; Öhman, Hanna ; Kivelä, Juha ; Kiviranta, Hannu ; Rantakokko, Panu ; Koponen, Jani ; Medgyesi, Danielle N. ; Kitahara, Cari M. ; McGlynn, Katherine A. ; Sampson, Joshua ; Albert, Paul S. ; Ward, Mary H. ; Jones, Rena R.</creatorcontrib><description>Human exposure to per‐ and polyfluoroalkyl substances (PFAS) occurs globally through contaminated food, dust, and drinking water. Studies of PFAS and thyroid cancer have been limited. We conducted a nested case‐control study of prediagnostic serum levels of 19 PFAS and papillary thyroid cancer (400 cases, 400 controls) in the Finnish Maternity Cohort (pregnancies 1986‐2010; follow‐up through 2016), individually matched on sample year and age. We used conditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for log2 transformed and categorical exposures, overall and stratified by calendar period, birth cohort, and median age at diagnosis. We adjusted for other PFAS with Spearman correlation rho = 0.3‐0.6. Seven PFAS, including perfluoroctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), N‐ethyl‐perfluorooctane sulfonamidoacetic acid (EtFOSAA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluorohexane sulfonic acid (PFHxS) were detected in &gt;50% of women. These PFAS were not associated with risk of thyroid cancer, except for PFHxS, which was inversely associated (OR log2 = 0.82, 95% CI: 0.70‐0.97). We observed suggestive but imprecise increased risks associated with PFOA, PFOS, and EtFOSAA for those diagnosed at ages &lt;40 years, whereas associations were null or inverse among those diagnosed at 40+ years (P‐interaction: .02, .08, .13, respectively). There was little evidence of other interactions. These results show no clear association between PFAS and papillary thyroid cancer risk. Future work would benefit from evaluation of these relationships among those with higher exposure levels and during periods of early development when the thyroid gland may be more susceptible to environmental harms. What's new? Per‐ and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that may increase thyroid cancer risk. Most PFAS studies of thyroid cancer were conducted in the United States and evaluated only perfluorooctanoic acid. Here, serum levels of 19 PFAS were measured in women in the Finnish Maternity Cohort to identify associations with thyroid cancer. Analyses reveal suggestive associations between PFAS and thyroid cancer risk for women under age 40 and no association or inverse associations for women over age 40. Further investigation is warranted to elucidate risks related to high PFAS exposure during early development.</description><identifier>ISSN: 0020-7136</identifier><identifier>ISSN: 1097-0215</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.34776</identifier><identifier>PMID: 37902275</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Acids ; Alkanesulfonic Acids ; Cancer ; Case-Control Studies ; Drinking water ; Environmental Pollutants ; Female ; Finland - epidemiology ; Fluorocarbons - adverse effects ; Food contamination ; Humans ; Medical research ; Papillary thyroid cancer ; Perfluorochemicals ; Perfluorodecanoic acid ; Perfluorohexane ; Perfluorooctane sulfonic acid ; Perfluorooctanoic acid ; persistent pollutants ; per‐ and polyfluoroalkyl substances ; PFAS ; PFOA ; PFOS ; Pregnancy ; Serum levels ; Sulfonic Acids ; Thyroid cancer ; Thyroid Cancer, Papillary - epidemiology ; Thyroid Neoplasms - epidemiology ; Thyroid Neoplasms - etiology</subject><ispartof>International journal of cancer, 2024-03, Vol.154 (6), p.979-991</ispartof><rights>2023 UICC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.</rights><rights>2024 UICC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3</citedby><cites>FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3</cites><orcidid>0000-0001-5303-5109 ; 0000-0001-6416-4432 ; 0000-0003-2329-9933 ; 0000-0001-8825-5750 ; 0000-0003-1294-1679</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37902275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madrigal, Jessica M.</creatorcontrib><creatorcontrib>Troisi, Rebecca</creatorcontrib><creatorcontrib>Surcel, Heljä‐Marja</creatorcontrib><creatorcontrib>Öhman, Hanna</creatorcontrib><creatorcontrib>Kivelä, Juha</creatorcontrib><creatorcontrib>Kiviranta, Hannu</creatorcontrib><creatorcontrib>Rantakokko, Panu</creatorcontrib><creatorcontrib>Koponen, Jani</creatorcontrib><creatorcontrib>Medgyesi, Danielle N.</creatorcontrib><creatorcontrib>Kitahara, Cari M.</creatorcontrib><creatorcontrib>McGlynn, Katherine A.</creatorcontrib><creatorcontrib>Sampson, Joshua</creatorcontrib><creatorcontrib>Albert, Paul S.</creatorcontrib><creatorcontrib>Ward, Mary H.</creatorcontrib><creatorcontrib>Jones, Rena R.</creatorcontrib><title>Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Human exposure to per‐ and polyfluoroalkyl substances (PFAS) occurs globally through contaminated food, dust, and drinking water. Studies of PFAS and thyroid cancer have been limited. We conducted a nested case‐control study of prediagnostic serum levels of 19 PFAS and papillary thyroid cancer (400 cases, 400 controls) in the Finnish Maternity Cohort (pregnancies 1986‐2010; follow‐up through 2016), individually matched on sample year and age. We used conditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for log2 transformed and categorical exposures, overall and stratified by calendar period, birth cohort, and median age at diagnosis. We adjusted for other PFAS with Spearman correlation rho = 0.3‐0.6. Seven PFAS, including perfluoroctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), N‐ethyl‐perfluorooctane sulfonamidoacetic acid (EtFOSAA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluorohexane sulfonic acid (PFHxS) were detected in &gt;50% of women. These PFAS were not associated with risk of thyroid cancer, except for PFHxS, which was inversely associated (OR log2 = 0.82, 95% CI: 0.70‐0.97). We observed suggestive but imprecise increased risks associated with PFOA, PFOS, and EtFOSAA for those diagnosed at ages &lt;40 years, whereas associations were null or inverse among those diagnosed at 40+ years (P‐interaction: .02, .08, .13, respectively). There was little evidence of other interactions. These results show no clear association between PFAS and papillary thyroid cancer risk. Future work would benefit from evaluation of these relationships among those with higher exposure levels and during periods of early development when the thyroid gland may be more susceptible to environmental harms. What's new? Per‐ and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that may increase thyroid cancer risk. Most PFAS studies of thyroid cancer were conducted in the United States and evaluated only perfluorooctanoic acid. Here, serum levels of 19 PFAS were measured in women in the Finnish Maternity Cohort to identify associations with thyroid cancer. Analyses reveal suggestive associations between PFAS and thyroid cancer risk for women under age 40 and no association or inverse associations for women over age 40. Further investigation is warranted to elucidate risks related to high PFAS exposure during early development.</description><subject>Acids</subject><subject>Alkanesulfonic Acids</subject><subject>Cancer</subject><subject>Case-Control Studies</subject><subject>Drinking water</subject><subject>Environmental Pollutants</subject><subject>Female</subject><subject>Finland - epidemiology</subject><subject>Fluorocarbons - adverse effects</subject><subject>Food contamination</subject><subject>Humans</subject><subject>Medical research</subject><subject>Papillary thyroid cancer</subject><subject>Perfluorochemicals</subject><subject>Perfluorodecanoic acid</subject><subject>Perfluorohexane</subject><subject>Perfluorooctane sulfonic acid</subject><subject>Perfluorooctanoic acid</subject><subject>persistent pollutants</subject><subject>per‐ and polyfluoroalkyl substances</subject><subject>PFAS</subject><subject>PFOA</subject><subject>PFOS</subject><subject>Pregnancy</subject><subject>Serum levels</subject><subject>Sulfonic Acids</subject><subject>Thyroid cancer</subject><subject>Thyroid Cancer, Papillary - epidemiology</subject><subject>Thyroid Neoplasms - epidemiology</subject><subject>Thyroid Neoplasms - etiology</subject><issn>0020-7136</issn><issn>1097-0215</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1DAUhS0EotPCghdAltjAIq2vf-J4iUYUilqVBawjx3EYTzN2sB2h7HiEPmOfpO5MywKJ1ZXu_c7R0T0IvQFyCoTQM7c1p4xLWT9DKyBKVoSCeI5W5UYqCaw-QscpbQkBEIS_REdMKkKpFCt0-y3a3umfPqTsDE42zjtsgjfW56izCz7hMODJxrs_t1j7Hk9hXIZxDjHo8WYZcZq7lHURpP05unSzV-jJjaOOC86bJQbXY_MARex82Vh87rx3aYOvdLbRu7zgddiEmF-hF4Mek339OE_Qj_NP39dfqsvrzxfrj5eVYYLVVd8LGGBgjQHOmKkVMMm0MsRwzoUVnehr1VvomlroxjS8G4igalBcKN6Zjp2g9wffKYZfs0253blkbInsbZhTS5uGQyNA0oK--wfdhjn6kq6lCiRQqKUs1IcDZWJIKdqhnaLblQe0QNqHmtpSU7uvqbBvHx3nbmf7v-RTLwU4OwC_3WiX_zu1F1_XB8t7SzmfQQ</recordid><startdate>20240315</startdate><enddate>20240315</enddate><creator>Madrigal, Jessica M.</creator><creator>Troisi, Rebecca</creator><creator>Surcel, Heljä‐Marja</creator><creator>Öhman, Hanna</creator><creator>Kivelä, Juha</creator><creator>Kiviranta, Hannu</creator><creator>Rantakokko, Panu</creator><creator>Koponen, Jani</creator><creator>Medgyesi, Danielle N.</creator><creator>Kitahara, Cari M.</creator><creator>McGlynn, Katherine A.</creator><creator>Sampson, Joshua</creator><creator>Albert, Paul S.</creator><creator>Ward, Mary H.</creator><creator>Jones, Rena R.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5303-5109</orcidid><orcidid>https://orcid.org/0000-0001-6416-4432</orcidid><orcidid>https://orcid.org/0000-0003-2329-9933</orcidid><orcidid>https://orcid.org/0000-0001-8825-5750</orcidid><orcidid>https://orcid.org/0000-0003-1294-1679</orcidid></search><sort><creationdate>20240315</creationdate><title>Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort</title><author>Madrigal, Jessica M. ; Troisi, Rebecca ; Surcel, Heljä‐Marja ; Öhman, Hanna ; Kivelä, Juha ; Kiviranta, Hannu ; Rantakokko, Panu ; Koponen, Jani ; Medgyesi, Danielle N. ; Kitahara, Cari M. ; McGlynn, Katherine A. ; Sampson, Joshua ; Albert, Paul S. ; Ward, Mary H. ; Jones, Rena R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acids</topic><topic>Alkanesulfonic Acids</topic><topic>Cancer</topic><topic>Case-Control Studies</topic><topic>Drinking water</topic><topic>Environmental Pollutants</topic><topic>Female</topic><topic>Finland - epidemiology</topic><topic>Fluorocarbons - adverse effects</topic><topic>Food contamination</topic><topic>Humans</topic><topic>Medical research</topic><topic>Papillary thyroid cancer</topic><topic>Perfluorochemicals</topic><topic>Perfluorodecanoic acid</topic><topic>Perfluorohexane</topic><topic>Perfluorooctane sulfonic acid</topic><topic>Perfluorooctanoic acid</topic><topic>persistent pollutants</topic><topic>per‐ and polyfluoroalkyl substances</topic><topic>PFAS</topic><topic>PFOA</topic><topic>PFOS</topic><topic>Pregnancy</topic><topic>Serum levels</topic><topic>Sulfonic Acids</topic><topic>Thyroid cancer</topic><topic>Thyroid Cancer, Papillary - epidemiology</topic><topic>Thyroid Neoplasms - epidemiology</topic><topic>Thyroid Neoplasms - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madrigal, Jessica M.</creatorcontrib><creatorcontrib>Troisi, Rebecca</creatorcontrib><creatorcontrib>Surcel, Heljä‐Marja</creatorcontrib><creatorcontrib>Öhman, Hanna</creatorcontrib><creatorcontrib>Kivelä, Juha</creatorcontrib><creatorcontrib>Kiviranta, Hannu</creatorcontrib><creatorcontrib>Rantakokko, Panu</creatorcontrib><creatorcontrib>Koponen, Jani</creatorcontrib><creatorcontrib>Medgyesi, Danielle N.</creatorcontrib><creatorcontrib>Kitahara, Cari M.</creatorcontrib><creatorcontrib>McGlynn, Katherine A.</creatorcontrib><creatorcontrib>Sampson, Joshua</creatorcontrib><creatorcontrib>Albert, Paul S.</creatorcontrib><creatorcontrib>Ward, Mary H.</creatorcontrib><creatorcontrib>Jones, Rena R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madrigal, Jessica M.</au><au>Troisi, Rebecca</au><au>Surcel, Heljä‐Marja</au><au>Öhman, Hanna</au><au>Kivelä, Juha</au><au>Kiviranta, Hannu</au><au>Rantakokko, Panu</au><au>Koponen, Jani</au><au>Medgyesi, Danielle N.</au><au>Kitahara, Cari M.</au><au>McGlynn, Katherine A.</au><au>Sampson, Joshua</au><au>Albert, Paul S.</au><au>Ward, Mary H.</au><au>Jones, Rena R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2024-03-15</date><risdate>2024</risdate><volume>154</volume><issue>6</issue><spage>979</spage><epage>991</epage><pages>979-991</pages><issn>0020-7136</issn><issn>1097-0215</issn><eissn>1097-0215</eissn><abstract>Human exposure to per‐ and polyfluoroalkyl substances (PFAS) occurs globally through contaminated food, dust, and drinking water. Studies of PFAS and thyroid cancer have been limited. We conducted a nested case‐control study of prediagnostic serum levels of 19 PFAS and papillary thyroid cancer (400 cases, 400 controls) in the Finnish Maternity Cohort (pregnancies 1986‐2010; follow‐up through 2016), individually matched on sample year and age. We used conditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for log2 transformed and categorical exposures, overall and stratified by calendar period, birth cohort, and median age at diagnosis. We adjusted for other PFAS with Spearman correlation rho = 0.3‐0.6. Seven PFAS, including perfluoroctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), N‐ethyl‐perfluorooctane sulfonamidoacetic acid (EtFOSAA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluorohexane sulfonic acid (PFHxS) were detected in &gt;50% of women. These PFAS were not associated with risk of thyroid cancer, except for PFHxS, which was inversely associated (OR log2 = 0.82, 95% CI: 0.70‐0.97). We observed suggestive but imprecise increased risks associated with PFOA, PFOS, and EtFOSAA for those diagnosed at ages &lt;40 years, whereas associations were null or inverse among those diagnosed at 40+ years (P‐interaction: .02, .08, .13, respectively). There was little evidence of other interactions. These results show no clear association between PFAS and papillary thyroid cancer risk. Future work would benefit from evaluation of these relationships among those with higher exposure levels and during periods of early development when the thyroid gland may be more susceptible to environmental harms. What's new? Per‐ and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that may increase thyroid cancer risk. Most PFAS studies of thyroid cancer were conducted in the United States and evaluated only perfluorooctanoic acid. Here, serum levels of 19 PFAS were measured in women in the Finnish Maternity Cohort to identify associations with thyroid cancer. Analyses reveal suggestive associations between PFAS and thyroid cancer risk for women under age 40 and no association or inverse associations for women over age 40. Further investigation is warranted to elucidate risks related to high PFAS exposure during early development.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37902275</pmid><doi>10.1002/ijc.34776</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-5303-5109</orcidid><orcidid>https://orcid.org/0000-0001-6416-4432</orcidid><orcidid>https://orcid.org/0000-0003-2329-9933</orcidid><orcidid>https://orcid.org/0000-0001-8825-5750</orcidid><orcidid>https://orcid.org/0000-0003-1294-1679</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2024-03, Vol.154 (6), p.979-991
issn 0020-7136
1097-0215
1097-0215
language eng
recordid cdi_proquest_miscellaneous_2884185172
source Wiley-Blackwell Read & Publish Collection
subjects Acids
Alkanesulfonic Acids
Cancer
Case-Control Studies
Drinking water
Environmental Pollutants
Female
Finland - epidemiology
Fluorocarbons - adverse effects
Food contamination
Humans
Medical research
Papillary thyroid cancer
Perfluorochemicals
Perfluorodecanoic acid
Perfluorohexane
Perfluorooctane sulfonic acid
Perfluorooctanoic acid
persistent pollutants
per‐ and polyfluoroalkyl substances
PFAS
PFOA
PFOS
Pregnancy
Serum levels
Sulfonic Acids
Thyroid cancer
Thyroid Cancer, Papillary - epidemiology
Thyroid Neoplasms - epidemiology
Thyroid Neoplasms - etiology
title Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A44%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prediagnostic%20serum%20concentrations%20of%20per%E2%80%90%20and%20polyfluoroalkyl%20substances%20and%20risk%20of%20papillary%20thyroid%20cancer%20in%20the%20Finnish%20Maternity%20Cohort&rft.jtitle=International%20journal%20of%20cancer&rft.au=Madrigal,%20Jessica%20M.&rft.date=2024-03-15&rft.volume=154&rft.issue=6&rft.spage=979&rft.epage=991&rft.pages=979-991&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.34776&rft_dat=%3Cproquest_cross%3E2884185172%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3536-dd51f1f38c1433c691373a9c0c4445e5b5d69de1b865a8c84bf0529f94594bcb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2917121677&rft_id=info:pmid/37902275&rfr_iscdi=true